Skip to main content

Advertisement

Log in

Probable sarcopenia: associations with common geriatric syndromes and comorbidities in Turkish geriatric patients from a university hospital

  • Research Paper
  • Published:
European Geriatric Medicine Aims and scope Submit manuscript

Key summary points

AbstractSection Aim

To identify the associations between probable sarcopenia and common geriatric syndromes in a sample of community-dwelling older adults.

AbstractSection Findings

The prevalence of probable sarcopenia was 12.7%; frailty, male sex and chronic kidney disease were identified as independent associations of sarcopenia.

AbstractSection Message

Frailty screening should be carried out and comorbidity status should be identified in the presence of probable sarcopenia without waiting for loss of muscle mass to ensure the early application of appropriate measures.

Abstract

Purpose

EWGSOP2 defines “probable sarcopenia” as the presence of low muscle strength without non-muscle causes. The associations of probable sarcopenia have been studied in few reports to date, and our intention in this study is to identify associations of probable sarcopenia with common geriatric syndromes in a sample of older adults who attended the geriatric outpatient clinic of Istanbul University Hospital.

Methods

The present study was designed as a retrospective cross-sectional study. We performed a comprehensive geriatric assessment to the participants. Univariate analyses were performed to determine relationship of probable sarcopenia with age, sex, common geriatric syndromes, i.e., frailty, falls, polypharmacy, malnutrition, and comorbidities, i.e., diabetes mellitus, hypertension, chronic kidney disease, chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), depression, osteoporosis, and the variables found to be significant were included in logistic regression analyses. The results are presented as an odds ratio (OR), with a 95% confidence interval (CI).

Results

Included in the study were 456 participants with a mean age of 74.6 ± 6.6 years, of which 71.1% were female. Probable sarcopenia was identified in 12.7% (n = 58) of the sample. A multivariate analysis was carried out, the factors associated with probable sarcopenia were identified as male sex (OR 0.269, 95% CI 0.142–0.510), frailty (OR 4.265, 95% CI 2.200–8.267) and chronic kidney disease (OR 3.084, 95% CI 1.105–8.608).

Conclusion

Probable sarcopenia was more significantly associated with frailty than with other geriatric syndromes, signifying its importance as a marker for frailty. The study further identified chronic renal failure as a factor significantly associated with probable sarcopenia among the variety of studied diseases that frequently accompany aging.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

Data are available from the authors upon reasonable request.

References

  1. Marzetti E, Calvani R, Tosato M et al (2017) SPRINTT Consortium sarcopenia: an overview. Aging Clin Exp Res 29(1):11–17

    Article  Google Scholar 

  2. Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 39:412–423

    Article  Google Scholar 

  3. Bahat G, Tufan A, Kilic C et al (2019) Cut-off points for weight and body mass index adjusted bioimpedance analysis measurements of muscle mass. Aging Clin Exp Res 31(7):935–942

    Article  Google Scholar 

  4. Bahat G, Kilic C, Ilhan B et al (2019) Association of different bioimpedanciometry estimations of muscle mass with functional measures. Geriatr Gerontol Int 19(7):593–597

    Google Scholar 

  5. Bahat G, Tufan A, Kilic C et al (2020) Cut-off points for height, weight and body mass index adjusted bioimpedance analysis measurements of muscle mass with use of different threshold definitions. Aging Male 23(5):382–387

    Article  Google Scholar 

  6. Mayhew AJ, Amog K, Phillips S et al (2018) The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses. Age Ageing 48:48–56

    Article  Google Scholar 

  7. Cruz-Jentoft AJ, Bahat G, Bauer J et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16–31

    Article  Google Scholar 

  8. Beaudart C, Zaaria M, Pasleau F et al (2017) Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS ONE 12(1):e0169548

    Article  Google Scholar 

  9. Landi F, Liperoti R, Fusco D et al (2012) Sarcopenia and mortality among older nursing home residents. J Am Med Dir Assoc 13:121–126

    Article  Google Scholar 

  10. Studenski S, Perera S, Patel K et al (2011) Gait speed and survival in older adults. JAMA 305:50–58

    Article  CAS  Google Scholar 

  11. Huang P, Luo K, Xu J et al (2021) Sarcopenia as a risk factor for future hip fracture: a meta-analysis of prospective cohort studies. J Nutr Health Aging 25:183–188

    Article  CAS  Google Scholar 

  12. Bahat G, Tufan A, Kilic C et al (2020) Prevalence of sarcopenia and its components in community-dwelling outpatient older adults and their relation with functionality. Aging Male 23(5):424–430

    Article  Google Scholar 

  13. Volaklis KA, Halle M, Thorand B et al (2016) Handgrip strength is inversely and independently associated with multimorbidity among older women: results from the KORA-age study. Eur J Intern Med 31:35–40

    Article  CAS  Google Scholar 

  14. Zhang XS, Liu YH, Zhang Y et al (2017) Handgrip strength as a predictor of nutritional status in Chinese elderly inpatients at hospital admission. Biomed Environ Sci 30(11):802–810

    CAS  Google Scholar 

  15. Dodds RM, Granic A, Robinson SM, Sayer AA (2020) Sarcopenia, long-term conditions, and multimorbidity: findings from UK biobank participants. J Cachexia Sarcopenia Muscle 11(1):62–68

    Article  Google Scholar 

  16. Sousa-Santos AR, Afonso C, Borges N et al (2019) Factors associated with sarcopenia and undernutrition in older adults. Nutr Diet 76:604–612

    Article  Google Scholar 

  17. Giglio J, Kamimura M, Lamarca F et al (2018) Association of sarcopenia with nutritional parameters, quality of life, hospitalization, and mortality rates of elderly patients on hemodialysis. J Ren Nutr 28(3):197–207

    Article  Google Scholar 

  18. Pérez-Sousa MÁ, Pozo-Cruz JD, Cano-Gutiérrez CA et al (2021) High prevalence of probable sarcopenia in a representative sample from Colombia: implications for geriatrics in latin America. J Am Med Dir Assoc 22(4):859-864.e1

    Article  Google Scholar 

  19. Katz S, Ford AB, Moskowitz RW et al (1963) Studies of illness in the aged the Index of Adl: a standardized measure of biological and psychosocial function. JAMA 185:914–919

    Article  CAS  Google Scholar 

  20. Lawton MP, Brody EM (1969) Assessment of older people: self-management. Gerontologist 9:179–186

    Article  CAS  Google Scholar 

  21. Guigoz Y, Vellas B, Garry PJ (1996) Assessing the nutritional status of the elderly: the mini nutritional assessment as part of the geriatric evaluation. Nutr Rev 54:59–65

    Article  Google Scholar 

  22. Rubenstein LZ, Harker JO, Salvà A et al (2001) Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF). J Gerontol: Ser A 56:366–372

    Article  Google Scholar 

  23. Ferner RE, Aronson JK (2006) Communicating information about drug safety. BMJ 333:143–145

    Article  CAS  Google Scholar 

  24. Morley JE, Malmstrom TK, Miller DK (2012) A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging 16:601–608

    Article  CAS  Google Scholar 

  25. Fess EE. Grip strength. In. Casanova JS, ed. Clinical Assessment Recommendations, 41–5.

  26. Massy-Westropp NM, Gill TK, Taylor AW, Bohannon RW, Hill CL (2011) Hand grip strength: age and gender stratified normative data in a population-based study. BMC Res Notes 4:127

    Article  Google Scholar 

  27. Wearing J, Konings P, de Bie RA et al (2020) Prevalence of probable sarcopenia in community-dwelling older Swiss people—-a cross-sectional study. BMC Geriatr 20(1):307

    Article  Google Scholar 

  28. Sobestiansky S, Michaelsson K, Cederholm T (2019) Sarcopenia prevalence and associations with mortality and hospitalisation by various sarcopenia definitions in 85–89 year old community-dwelling men: a report from the ULSAM study. BMC Geriatr 19(1):318

    Article  Google Scholar 

  29. Tsekoura M, Billis E, Matzaroglou C et al (2021) Prevalence of probable sarcopenia in community-dwelling older Greek people. J Frailty Sarcopenia Falls. 6(4):204–208

    Article  Google Scholar 

  30. Marincolo JCS, Aprahamian I, Corona LP et al (2021) Three definitions of probable sarcopenia and associations with falls and functional disability among community-dwelling older adults. Osteoporos Sarcopenia 7(2):69–74

    Article  Google Scholar 

  31. Cipolli GC, Aprahamian I, Borim FSA et al (2021) Probable sarcopenia is associated with cognitive impairment among community-dwelling older adults: results from the FIBRA study. Arq Neuropsiquiatr 79(5):376–383

    Article  Google Scholar 

  32. Clegg A, Young J, Iliffe S et al (2013) Frailty in elderly people. Lancet 381:752–762

    Article  Google Scholar 

  33. Cruz-Jentoft AJ, Kiesswetter E, Drey M, Sieber CC (2017) Nutrition, frailty, and sarcopenia. Aging Clin Exp Res 29(1):43–48

    Article  Google Scholar 

  34. Samper-Ternent R, Reyes-Ortiz C, Ottenbacher KJ et al (2016) Frailty and sarcopenia in Bogotá: results from the SABE Bogotá Study. Aging Clin Exp Res 29(2):265–272

    Article  Google Scholar 

  35. Bahat G, Kilic C, Altinkaynak M et al (2020) Comparison of standard versus population-specific handgrip strength cut-off points in the detection of probable sarcopenia after launch of EWGSOP2. Aging Male 23(5):1564–1569

    Article  Google Scholar 

  36. Vermeiren S, Vella-Azzopardi R, Beckwée D et al (2016) Frailty and the prediction of negative health outcomes: a meta-analysis. J Am Med Dir Assoc 17(12):1163.e1-1163.e17

    Article  Google Scholar 

  37. Beaudart C, McCloskey E, Bruyère O et al (2016) Sarcopenia in daily practice: assessment and management. BMC Geriatr 16(1):170

    Article  Google Scholar 

  38. Wang XH, Mitch WE (2014) Mechanisms of muscle wasting in chronic kidney disease. Nat Rev Nephrol 10:504–516

    Article  CAS  Google Scholar 

  39. Isoyama N, Qureshi A, Avesani C et al (2014) Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clin J Am Soc Nephrol 9(10):1720–1728

    Article  Google Scholar 

  40. Kittiskulnam P, Chertow G, Carrero J et al (2017) Sarcopenia and its individual criteria are associated, in part with mortality among patients on hemodialysis. Kidney Int 92(1):238–247

    Article  Google Scholar 

  41. D’Alessandro C, Piccoli GB, Barsotti M et al (2018) Prevalence and correlates of sarcopenia among elderly CKD outpatients on tertiary care. Nutrients 10(12):1951

    Article  Google Scholar 

  42. Lamarca F, Carrero JJ, Rodrigues JC et al (2014) Prevalence of sarcopenia in elderly maintenance hemodialysis patients: the impact of different diagnostic criteria. J Nutr Health Aging 18(7):710–717

    Article  CAS  Google Scholar 

  43. Pereira RA, Cordeiro AC, Avesani CM et al (2015) Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality. Nephrol Dial Transplant 30(10):1718–1725

    Article  CAS  Google Scholar 

  44. Wilkinson TJ, Miksza J, Yates T, Lightfoot CJ, Baker LA, Watson EL, Zaccardi F, Smith AC (2021) Association of sarcopenia with mortality and end-stage renal disease in those with chronic kidney disease: a UK biobank study. J Cachexia Sarcopenia Muscle 12(3):586–598

    Article  Google Scholar 

  45. Noncommunicable diseases: risk factors. In: Global Health Observatory [website]. Geneva: World Health Organization; 2022 (https://www.who.int/data/gho/data/themes/topics/noncommunicable-diseases-risk-factors)

  46. Satman I, Omer B, Tutuncu Y et al (2013) Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 28(2):169–180

    Article  Google Scholar 

  47. Sugimoto K, Tabara Y, Ikegami H et al (2019) Hyperglycemia in non-obese patients with type 2 diabetes is associated with low muscle mass: the multicenter study for clarifying evidence for sarcopenia in patients with diabetes mellitus. J Diabetes Investig 10:1471–1479

    Article  CAS  Google Scholar 

  48. Liccini A, Malmstrom TK (2016) Frailty and sarcopenia as predictors of adverse health outcomes in persons with diabetes Mellitus. J Am Med Dir Assoc 17:846–851

    Article  Google Scholar 

  49. de Freitas MM, de Oliveira VLP, Grassi T et al (2020) Difference in sarcopenia prevalence and associated factors according to 2010 and 2018 European consensus (EWGSOP) in elderly patients with type 2 diabetes mellitus. Exp Gerontol 132:110835

    Article  Google Scholar 

  50. Anagnostis P, Gkekas NK, Achilla C et al (2020) Type 2 diabetes mellitus is associated with increased risk of sarcopenia: a systematic review and meta-analysis. Calcif Tissue Int 107:453–463

    Article  CAS  Google Scholar 

  51. Izzo A, Massimino E, Riccardi G, Della PG (2021) A narrative review on sarcopenia in type 2 diabetes mellitus: prevalence and associated factors. Nutrients 13(1):183

    Article  Google Scholar 

  52. Remelli F, Maietti E, Abete P et al (2022) Prevalence of obesity and diabetes in older people with sarcopenia defined according to EWGSOP2 and FNHI criteria. Aging Clin Exp Res 34(1):113–120

    Article  Google Scholar 

  53. Çeliker M, Selçuk MY, Olt S (2018) Sarcopenia in diabetic nephropathy: a cross-sectional study. Rom J Intern Med 56:102–108

    Google Scholar 

  54. van Bakel SIJ, Gosker HR, Langen RC, Schols AMWJ (2021) Towards personalized management of sarcopenia in COPD. Int J Chron Obstruct Pulmon Dis 16:25–40

    Article  Google Scholar 

  55. Zhang Y, Zhang J, Ni W et al (2021) Sarcopenia in heart failure: a systematic review and meta-analysis. ESC Heart Fail 8(2):1007–1017

    Article  Google Scholar 

  56. Hanada M, Sakamoto N, Ishimatsu Y et al (2016) Effect of long-term treatment with corticosteroids on skeletal muscle strength, functional exercise capacity and health status in patients with interstitial lung disease. Respirology 21(6):1088–1093

    Article  Google Scholar 

  57. Langen RC, Gosker HR, Remels AH, Schols AM (2013) Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease. Int J Biochem Cell Biol 45(10):2245–2256

    Article  CAS  Google Scholar 

  58. Budui SL, Rossi AP, Zamboni M (2015) The pathogenetic bases of sarcopenia. Clin Cases Miner Bone Metab 12:22–26

    Google Scholar 

  59. Delibaş DH, Eşkut N, İlhan B et al (2021) Clarifying the relationship between sarcopenia and depression in geriatric outpatients. Aging Male 24(1):29–36

    Article  Google Scholar 

  60. Byeon CH, Kang KY, Kang SH et al (2016) Sarcopenia is not associated with depression in Korean adults: results from the 2010–2011 Korean national health and nutrition examination survey. Korean J Fam Med 37:37–43

    Article  Google Scholar 

  61. Anderson LJ, Liu H, Garcia JM (2017) Sex differences in muscle wasting. Adv Exp Med Biol 1043:153–197

    Article  CAS  Google Scholar 

  62. Tseng LA, Delmonico MJ, Visser M et al (2014) Body composition explains sex differential in physical performance among older adults. J Gerontol Ser, Biol Sci Med Sci 69:93–100

    Article  Google Scholar 

  63. Erbas Sacar D, Kilic C, Karan MA, Bahat G (2021) Ability of SARC-F to find probable sarcopenia cases in older adults. J Nutr Health Aging 25(6):757–761

    Article  CAS  Google Scholar 

  64. Beaudart C, Rizzoli R, Bruyère O et al (2014) Sarcopenia: burden and challenges for public health. Arch Public Health 72(1):45

    Article  Google Scholar 

Download references

Acknowledgements

Duygu Erbas Sacar, Cihan Kilic, Meryem Merve Oren, Tugba Erdogan, Serdar Ozkok, Caglar Ozer Aydın, Nezahat Muge Catikkas, Mehmet Akif Karan and Gulistan Bahat confirm their compliance with the ethical guidelines related to the authorship and publishing of the European Geriatric Medicine.

Funding

This research did not benefit from any specific grant from any funding agency operating in the public, commercial or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Contributions

DES: conceptualization, methodology, writing—original draft preparation, writing—review and editing, and formal analysis. CK: formal analysis. MMO: data curation and formal analysis. TE: data curation. SO: data curation. COA: data curation. NMC: data curation. MAK: writing—review and editing and supervision. GB: writing—review and editing and supervision. All the authors have read and approved the final manuscript.

Corresponding author

Correspondence to Duygu Erbas Sacar.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Ethical approval

Ethical approval was granted by the Istanbul University Istanbul Medical School ethical Board.

Consent to participate

Informed consent was provided by all the participants.

Consent for publication

Informed consent for publication was provided by all the participants.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Erbas Sacar, D., Kılıc, C., Oren, M.M. et al. Probable sarcopenia: associations with common geriatric syndromes and comorbidities in Turkish geriatric patients from a university hospital. Eur Geriatr Med 13, 1299–1308 (2022). https://doi.org/10.1007/s41999-022-00691-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s41999-022-00691-9

Keywords

Navigation